These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 9624390)
41. Cyclin-dependent kinase inhibitor p27 is related to cell proliferation and prognosis in laryngeal squamous cell carcinomas. Tamura N; Dong Y; Sui L; Tai Y; Sugimoto K; Nagahata S; Tokuda M J Laryngol Otol; 2001 May; 115(5):400-6. PubMed ID: 11410133 [TBL] [Abstract][Full Text] [Related]
42. [Analysis of proliferating cell nuclear antigen (PCNA) expression in 24 cases of primary non-small cell pulmonary carcinomas and correlation with survival]. Castellano VM; Sotelo T; Ballestín C; López-Encuentra A; Varela G Arch Bronconeumol; 1996 Mar; 32(3):127-31. PubMed ID: 8634790 [TBL] [Abstract][Full Text] [Related]
43. Proliferating cell nuclear antigen (PCNA) overexpression and microvessel density predict survival in the urinary bladder carcinoma. El-kott AF; El-baz MA; Mokhtar AA Int Urol Nephrol; 2006; 38(2):237-42. PubMed ID: 16868689 [TBL] [Abstract][Full Text] [Related]
44. Immunohistochemically stained markers (p53, PCNA, bcl-2) in dysplastic lesions of the larynx. Krecicki T; Jeleń M; Zalesska-Krecicka M; Szkudlarek T; Szajowski K Cancer Lett; 1999 Aug; 143(1):23-8. PubMed ID: 10465333 [TBL] [Abstract][Full Text] [Related]
45. Enhanced polymer one-step staining for proliferating cell nuclear antigen in squamous cell carcinoma of the tongue. Sano K; Sekine J; Inokuchi T; Pe MB; Ma G Biotech Histochem; 1996 Nov; 71(6):273-7. PubMed ID: 8957552 [TBL] [Abstract][Full Text] [Related]
46. The immunohistochemical expression of p21WAF1/Cip1 and Proliferating cell nuclear antigen in laryngeal squamous cell carcinomas. Li X; Izumaru S; Sakamoto K; Miyajima Y; Nakashima T J Laryngol Otol; 2006 Dec; 120(12):1042-8. PubMed ID: 16995968 [TBL] [Abstract][Full Text] [Related]
47. Prognostic values of proliferating cell nuclear antigen (PCNA) and Ki-67 for radiotherapy of oesophageal squamous cell carcinomas. Okuno Y; Nishimura Y; Kashu I; Ono K; Hiraoka M Br J Cancer; 1999 May; 80(3-4):387-95. PubMed ID: 10408843 [TBL] [Abstract][Full Text] [Related]
48. Prediction of occult neck metastases in laryngeal carcinoma: role of proliferating cell nuclear antigen, MIB-1, and E-cadherin immunohistochemical determination. Franchi A; Gallo O; Boddi V; Santucci M Clin Cancer Res; 1996 Oct; 2(10):1801-8. PubMed ID: 9816133 [TBL] [Abstract][Full Text] [Related]
49. Expression form of p53 and PCNA at the invasive front in oral squamous cell carcinoma: correlation with clinicopathological features and prognosis. Kato K; Kawashiri S; Yoshizawa K; Kitahara H; Okamune A; Sugiura S; Noguchi N; Yamamoto E J Oral Pathol Med; 2011 Oct; 40(9):693-8. PubMed ID: 21501231 [TBL] [Abstract][Full Text] [Related]
50. Prognostic value of nucleolar organiser regions (AgNORs) in laryngeal cancer. Krecicki T; Jeleń M; Zalesska-Krecicka M; Rak J; Szajowski K Acta Otorhinolaryngol Belg; 1998; 52(3):215-21. PubMed ID: 9810456 [TBL] [Abstract][Full Text] [Related]
52. p53, epidermal growth factor receptor and proliferating cell nuclear antigen in laryngeal squamous cell carcinoma are not predictive markers for the effect of adjuvant radiotherapy. Jiang H; Yang BB Acta Otolaryngol; 2009 Jan; 129(1):101-7. PubMed ID: 18607952 [TBL] [Abstract][Full Text] [Related]
53. Sequential increases in proliferating cell nuclear antigen expression in head and neck tumorigenesis: a potential biomarker. Shin DM; Voravud N; Ro JY; Lee JS; Hong WK; Hittelman WN J Natl Cancer Inst; 1993 Jun; 85(12):971-8. PubMed ID: 8098774 [TBL] [Abstract][Full Text] [Related]
54. Prognostic significance of cell kinetics in laryngeal squamous cell carcinoma: clinicopathological associations. Tomasino RM; Daniele E; Bazan V; Morello V; Tralongo V; Nuara R; Nagar C; Salvato M; Ingria F; Restivo S Cancer Res; 1995 Dec; 55(24):6103-8. PubMed ID: 8521400 [TBL] [Abstract][Full Text] [Related]
55. p53, PCNA and Ki67 in laryngeal cancer. Golusiński W; Olofsson J; Szmeja Z; Majewski P Pol J Pathol; 1996; 47(4):175-82. PubMed ID: 9097709 [TBL] [Abstract][Full Text] [Related]
56. Clinical relevance of cyclin B1 overexpression in laryngeal squamous cell carcinoma. Dong Y; Sui L; Watanabe Y; Sugimoto K; Tokuda M Cancer Lett; 2002 Mar; 177(1):13-9. PubMed ID: 11809526 [TBL] [Abstract][Full Text] [Related]
57. Prognostic significance of proliferating cell nuclear antigen (PCNA) in squamous cell carcinoma of the esophagus. Kinugasa S; Tachibana M; Hishikawa Y; Abe S; Yoshimura H; Monden N; Dhar DK; Nagasue N Jpn J Clin Oncol; 1996 Dec; 26(6):405-10. PubMed ID: 9001344 [TBL] [Abstract][Full Text] [Related]
58. HLA class I antigen down-regulation in primary laryngeal squamous cell carcinoma lesions as a poor prognostic marker. Ogino T; Shigyo H; Ishii H; Katayama A; Miyokawa N; Harabuchi Y; Ferrone S Cancer Res; 2006 Sep; 66(18):9281-9. PubMed ID: 16982773 [TBL] [Abstract][Full Text] [Related]
59. C-erbB-2 immunostaining in laryngeal cancer. Krecicki T; Jeleń M; Zalesska-Krecicka M Acta Otolaryngol; 1999; 119(3):392-5. PubMed ID: 10380748 [TBL] [Abstract][Full Text] [Related]
60. [Expression of p53, p21, PCNA and COX-2 and its relationship with recurrence in the early-stage laryngeal cancer with negative surgical margin]. Zeng R Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Mar; 30(5):349-52, 356. PubMed ID: 27382672 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]